GENO.ST
Price:
$20.05
Market Cap:
$1.31B
Genovis AB (publ.) designs, develops, and sells tools for development of drugs for customers in the pharmaceutical and medical device industries. The company offers FabALACTICA, a cysteine protease that digests human IgG1; FabRICATOR, an enzyme that primarily digests the hinge region of IgG; and FabRICATOR Z, an enzyme for the digestion of mouse IgG2a and IgG3, as well as for generating a homogenous pool of F(ab')2 and Fc fragments. It also provides FabULOUS (SpeB), an enzyme for the digestion of IgG in the hinge region; and GingisKHAN, a cysteine protease that digests human IgG1 at a specific site above the hinge. In addition, the company offers GingisREX, a cysteine protease that specifica...[Read more]
Industry
Biotechnology
IPO Date
2008-06-02
Stock Exchange
STO
Ticker
GENO.ST
According to Genovis AB (publ.)’s latest financial reports and current stock price. The company's current PE Ratio is 77.12. This represents a change of -120.90% compared to the average of -369.04 of the last 4 quarters.
The mean historical PE Ratio of Genovis AB (publ.) over the last ten years is 71.53. The current 77.12 PE Ratio has changed 10.68% with respect to the historical average. Over the past ten years (40 quarters), GENO.ST's PE Ratio was at its highest in in the September 2021 quarter at 1.11K. The PE Ratio was at its lowest in in the December 2023 quarter at -2016.72.
Average
71.53
Median
26.99
Minimum
-249.14
Maximum
318.08
Discovering the peaks and valleys of Genovis AB (publ.) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 951.08%
Maximum Annual PE Ratio = 318.08
Minimum Annual Increase = -166.29%
Minimum Annual PE Ratio = -249.14
Year | PE Ratio | Change |
---|---|---|
2023 | 55.35 | -79.41% |
2022 | 268.80 | 39.36% |
2021 | 192.88 | -39.36% |
2020 | 318.08 | 92.60% |
2019 | 165.16 | -166.29% |
2018 | -249.14 | 951.08% |
2017 | -23.70 | 199.89% |
2016 | -7.90 | 177.05% |
2015 | -2.85 | 107.29% |
2014 | -1.38 | -68.91% |
The current PE Ratio of Genovis AB (publ.) (GENO.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
172.34
5-year avg
200.05
10-year avg
71.53
Genovis AB (publ.)’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genovis AB (publ.) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Genovis AB (publ.) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Genovis AB (publ.)'s PE Ratio?
How is the PE Ratio calculated for Genovis AB (publ.) (GENO.ST)?
What is the highest PE Ratio for Genovis AB (publ.) (GENO.ST)?
What is the 3-year average PE Ratio for Genovis AB (publ.) (GENO.ST)?
What is the 5-year average PE Ratio for Genovis AB (publ.) (GENO.ST)?
How does the current PE Ratio for Genovis AB (publ.) (GENO.ST) compare to its historical average?